Temperature control in critically ill patients with a novel esophageal cooling device: a case series

被引:14
|
作者
Hegazy, Ahmed F. [1 ]
Lapierre, Danielle M. [1 ]
Butler, Ron [1 ]
Althenayan, Eyad [2 ]
机构
[1] Univ Western Ontario, London Hlth Sci Ctr, Univ Hosp, Dept Anesthesia & Perioperat Med, London, ON N6A 5A5, Canada
[2] Univ Western Ontario, London Hlth Sci Ctr, Univ Hosp, Dept Med,Div Crit Care, London, ON N6A 5A5, Canada
来源
BMC ANESTHESIOLOGY | 2015年 / 15卷
关键词
EMERGENCY CARDIOVASCULAR CARE; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; FEVER CONTROL; BRAIN-INJURY; MANAGEMENT; INDUCTION; CARDIOPULMONARY; RESUSCITATION; NORMOTHERMIA;
D O I
10.1186/s12871-015-0133-6
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Mild hypothermia and fever control have been shown to improve neurological outcomes post cardiac arrest. Common methods to induce hypothermia include body surface cooling and intravascular cooling; however, a new approach using an esophageal cooling catheter has recently become available. Methods: We report the first three cases of temperature control using an esophageal cooling device (ECD). The ECD was placed in a similar fashion to orogastric tubes. Temperature reduction was achieved by connecting the ECD to a commercially available external heat exchange unit (Blanketrol Hyperthermia - Hypothermia System). Results: The first patient, a 54 year-old woman (86 kg) was admitted after resuscitation from an out-of-hospital non-shockable cardiac arrest. Shortly after admission, she mounted a fever peaking at 38.3 degrees C despite administration of cold intravenous saline and application of cooling blankets. ECD utilization resulted in a temperature reduction to 35.7 degrees C over a period of 4 h. She subsequently recovered and was discharged home at day 23. The second patient, a 59 year-old man (73 kg), was admitted after successful resuscitation from a protracted out-of hospital cardiac arrest. His initial temperature was 35 degrees C, but slowly increased to 35.8 degrees C despite applying a cooling blanket and ice packs. The ECD was inserted and a temperature reduction to 34.8 degrees C was achieved within 3 h. The patient expired on day 3. The third patient, a 47 year-old man (95 kg) presented with a refractory fever secondary to necrotizing pneumonia in the postoperative period after coronary artery bypass grafting. His fever persisted despite empiric antibiotics, antipyretics, cooling blankets, and ice packs. ECD insertion resulted in a decrease in temperature from 39.5 to 36.5 degrees C in less than 5 h. He eventually made a favorable recovery and was discharged home after 59 days. In all 3 patients, device placement occurred in under 3 min and ease-of-use was reported as excellent by nursing staff and physicians. Conclusions: The esophageal cooling device was found to be an effective temperature control modality in this small case series of critically ill patients. Preliminary data presented in this report needs to be confirmed in large randomized controlled trials comparing its efficacy and safety to standard temperature control modalities.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] A GOOD DEATH: TERMINAL EXTUBATION AT HOME FOR CRITICALLY ILL PATIENTS: A CASE SERIES
    Stokem, Katie
    Carpenter, Valerie
    Glisic, Elizabeth
    Whitten, Sally
    Adams, Danalyn
    Maiorano, Christina
    Lerwick, Patricia
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 231 - 231
  • [22] Nebulized tranexamic acid for recurring hemoptysis in critically ill patients: case series
    Fatimah Alabdrabalnabi
    Mohammed Alshahrani
    Nadia Ismail
    International Journal of Emergency Medicine, 2020, 13
  • [23] TOTAL BODY COOLING IN CRITICALLY ILL FEBRILE PATIENTS
    REEVES, MM
    LEWIS, FJ
    SURGERY, 1958, 44 (01) : 84 - 90
  • [24] Liver injury in critically ill patients with COVID-19: a case series
    Cardoso, Filipe S.
    Pereira, Rui
    Germano, Nuno
    CRITICAL CARE, 2020, 24 (01):
  • [25] L-carnitine in critically ill patients-a case series study
    Oami T.
    Oshima T.
    Hattori N.
    Teratani A.
    Honda S.
    Yoshida T.
    Oda S.
    Renal Replacement Therapy, 4 (1)
  • [26] Care of critically ill pregnant patients with coronavirus disease 2019: a case series
    Hirshberg, Adi
    Kern-Goldberger, Adina R.
    Levine, Lisa D.
    Pierce-Williams, Rebecca
    Short, William R.
    Parry, Samuel
    Berghella, Vincenzo
    Triebwasser, Jourdan E.
    Srinivas, Sindhu K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (02) : 286 - 290
  • [27] Nebulized tranexamic acid for recurring hemoptysis in critically ill patients: case series
    Alabdrabalnabi, Fatimah
    Alshahrani, Mohammed
    Ismail, Nadia
    INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE, 2020, 13 (01)
  • [28] Bacterial Pneumonia in COVID-19 Critically Ill Patients: A Case Series
    Dudoignon, Emmanuel
    Camelena, Francois
    Deniau, Benjamin
    Habay, Adrien
    Coutrot, Maxime
    Ressaire, Quentin
    Plaud, Benoit
    Bercot, Beatrice
    Depret, Francois
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (05) : 905 - 906
  • [29] Glucose control in critically ill patients
    Flower, O.
    Finfer, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (01) : 4 - 6
  • [30] CASE SERIES OF COCCIDIOIDOMYCOSIS IN CRITICALLY ILL INFANTS AND CHILDREN
    Puranik, N.
    Hernandez, R.
    Dimand, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 232 - 233